{"id":"NCT03342898","sponsor":"Takeda","briefTitle":"Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults","officialTitle":"A Randomized, Observer-Blind, Placebo-Controlled, Phase 3 Trial to Investigate the Immunogenicity and Safety of a Tetravalent Dengue Vaccine Candidate and a Yellow Fever YF-17D Vaccine Administered Concomitantly and Sequentially in Healthy Subjects Aged 18 to 60 Years in Non-Endemic Country(Ies)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-02-28","primaryCompletion":"2018-05-09","completion":"2019-05-22","firstPosted":"2017-11-17","resultsPosted":"2020-10-08","lastUpdate":"2020-10-08"},"enrollment":900,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Dengue"],"interventions":[{"type":"BIOLOGICAL","name":"YF-17D","otherNames":[]},{"type":"BIOLOGICAL","name":"TDV","otherNames":["TAK-003","DENVax"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Group 1: YF-17D + Placebo/TDV/TDV","type":"EXPERIMENTAL"},{"label":"Group 2: TDV + Placebo/TDV/YF-17D","type":"EXPERIMENTAL"},{"label":"Group 3: TDV + YF-17D/TDV/Placebo","type":"EXPERIMENTAL"}],"summary":"The main purpose of this study is to assess the immunogenicity and safety of the concomitant and sequential administration of yellow fever (YF) vaccine and tetravalent dengue vaccine (TDV) in healthy participants aged 18 to 60 years living in country non-endemic for both dengue and YF.","primaryOutcome":{"measure":"Percentage of Participants Who Are YF and Dengue Virus (DENV)-Naive at Baseline and Are Seroprotected Against YF on Day 30 as Measured by Plaque Reduction Neutralization Test (PRNT)","timeFrame":"Day 30","effectByArm":[{"arm":"Group 1: YF-17D + Placebo/TDV/TDV","deltaMin":99.5,"sd":null},{"arm":"Group 2: TDV + Placebo/TDV/YF-17D","deltaMin":9.8,"sd":null},{"arm":"Group 3: TDV + YF-17D/TDV/Placebo","deltaMin":99.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":11,"countries":["United States"]},"refs":{"pmids":["40099800","36888687"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":300},"commonTop":["Upper respiratory tract infection","Injection site bruising","Injection site pruritus"]}}